Related Experiment Video

Updated: Jul 2, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Dementia in a patient with Fahr's syndrome

Katerina Konupcíková1, Jirí Masopust, Martin Valis

  • 1Department of Psychiatry, Charles University in Prague, Faculty of Medicine, Czech Republic. konupcikovak@lfhk.cuni.cz

Neuro Endocrinology Letters
|September 4, 2008
PubMed

Insights

Fahr disease involves brain calcification, often causing movement and behavioral issues. This case highlights severe dementia with mild symptoms, showing extensive calcifications and uneven brain perfusion.

Area of Science:

  • Neurology
  • Radiology
  • Metabolic Disorders

Background:

  • Fahr disease is defined by idiopathic basal ganglia calcification, potentially linked to movement and behavioral disorders.
  • Fahr syndrome shares pathology but stems from distinct underlying diseases, including calcium/phosphate metabolic issues like hypoparathyroidism.

Observation:

  • A 62-year-old male presented with severe dementia, minimal movement disorders, and subtle calcium metabolism abnormalities.
  • Extensive brain calcifications were identified in the patient.
  • Single-photon emission tomography revealed unevenly distributed cerebral perfusion.

Findings:

  • The case demonstrates Fahr disease presenting predominantly with severe dementia, diverging from typical presentations.
  • Mild neurological deficits and minor metabolic disturbances were noted despite significant intracranial calcifications.
  • Cerebral perfusion deficits correlated with the observed calcifications.

Implications:

  • This case expands the clinical spectrum of Fahr disease, emphasizing dementia as a primary symptom.
  • It underscores the importance of neuroimaging and perfusion studies in diagnosing Fahr disease, even with atypical clinical features.
  • Further research into the relationship between calcification patterns, perfusion deficits, and cognitive decline in Fahr disease is warranted.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...